Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 372Neoplasms 263Prostatic Neoplasms 188Lung Neoplasms 137Colorectal Neoplasms 128Head and Neck Neoplasms 76Colonic Neoplasms 67Pancreatic Neoplasms 63Carcinoma, Non-Small-Cell Lung 63Carcinoma, Hepatocellular 61Uterine Cervical Neoplasms 57Multiple Myeloma 54Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Neoplasm Metastasis 51Leukemia, Myeloid, Acute 50Brain Neoplasms 48Liver Neoplasms 44Rectal Neoplasms 42Melanoma 42Motor Activity 41Lymphoma, Non-Hodgkin 41Lymphoma 39Leukemia 38Pain 37Ovarian Neoplasms 36Hodgkin Disease 36Fatigue 34Depression 34Barrett Esophagus 34Lymphoma, Follicular 33

Interventions

zirconium-89-trastuzumab 1Positron Emission Tomography Computed Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Has results × Breast Cancer Metastases × Clear all
NCT02286843 2021-06-18

Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?

Memorial Sloan Kettering Cancer Center

Phase NA Completed
49 enrolled 8 charts
Breast

Breast Cancer Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡